Exagen Inc. (XGN) at a glance

Exagen Inc. (XGN) is a micro-cap Healthcare company. It trades at $7.39, with a -26.6% profit margin and revenue growth of 15.9%. It does not pay a dividend. Vestovix scores it 42/100 overall. Its strongest dimension is Growth (75/100) and its weakest is Safety (12/100). It carries above-market volatility, so expect larger swings.

Price

$7.39

Market cap

$179.0M

P/E ratio

n/a

Dividend yield

None

Beta

2.03

52-week range

$2.59 to $12.23